Process optimization and antidepression multi-target mechanisms of Total Flavonoids from Hemerocallis citrina Baroni: An integrated approach combining DES-UAE, network pharmacology, and experimental validation

This study optimized a green deep eutectic solvent extraction method for total flavonoids from *Hemerocallis citrina* and validated their multi-target antidepressant mechanism, which involves suppressing neuroinflammation and modulating the HPA axis via the PI3K-AKT pathway, through integrated network pharmacology and in vitro experiments.

The Gist

🌼 The Big Picture: Finding a Natural Mood Booster

Imagine your brain is like a busy city. When you are depressed, it's like the city is in a traffic jam, the power grid is flickering, and the streets are covered in trash (inflammation). Usually, doctors give you a single key (a standard antidepressant drug) to try to fix the traffic. But sometimes, that key doesn't fit all the locks, or it has annoying side effects.

This study is about Daylilies (a flower called Hemerocallis citrina). For over 1,000 years, people in China have used this flower to "calm the mind." The researchers wanted to prove why it works and find the best way to harvest its healing powers without using toxic chemicals.

They did this in three main steps: Harvesting, Mapping, and Testing.

---

Step 1: The Harvest (Getting the Good Stuff Out)

The Problem: Traditionally, to get the medicine out of the flower, you soak it in alcohol or water. It's like trying to get honey out of a comb with a spoon—slow and messy. Plus, alcohol isn't very "green" (eco-friendly).

The Solution: The researchers invented a new way using a "Deep Eutectic Solvent" (DES).

• The Analogy: Think of DES as a super-charged, eco-friendly sponge. It's made by mixing two safe, natural ingredients (choline chloride and ethylene glycol) that stick together to form a liquid that loves to grab onto the flower's healing compounds.
• The Process: They used ultrasound (like a high-tech sonic toothbrush) to vibrate the flower while it sat in this "sponge." This shook the healing compounds loose much faster than soaking.
• The Result: They found the perfect recipe (temperature, time, and amount of water) to squeeze out the maximum amount of healing juice. They got a very high yield of Total Flavonoids (the active "healing agents" in the flower).

---

Step 2: The Map (Predicting How It Works)

The Problem: Once they had the juice, they had a million tiny ingredients in it. How do you know which one fixes the "traffic jam" in the brain?

The Solution: They used Network Pharmacology.

• The Analogy: Imagine the brain is a giant, complex video game with thousands of characters (proteins) and quests (pathways). Depression is a glitch in the game.
  • Instead of guessing, they used a super-computer map. They fed the list of flower ingredients into the computer and asked: "Which game characters do these ingredients talk to?"
  • The computer built a giant web showing that the flower doesn't just fix one thing; it talks to six main bosses (targets like AKT1, TNF, IL6) that control inflammation, cell survival, and mood.
  • It predicted that the flower works by three main strategies:
    1. Turning down the fire: Reducing inflammation (like putting out a forest fire).
    2. Feeding the cells: Boosting "Brain-Derived Neurotrophic Factor" (BDNF), which is like fertilizer for brain cells.
    3. Calming the stress: Fixing the body's stress hormone system (the HPA axis).

The Check: They also did a Molecular Docking test.

• The Analogy: This is like a digital lock-and-key test. They simulated putting the flower's molecules into the computer models of the brain's "locks." The computer confirmed that the flower's keys fit the locks perfectly, proving the theory was likely correct.

---

Step 3: The Test (Proving It in the Lab)

The Problem: Computer maps are great, but we need to see if it actually works on real cells.

The Solution: They grew brain cells (PC-12 cells) in a petri dish and "stressed" them out using Corticosterone (a stress hormone).

• The Analogy: Imagine the cells are little soldiers. The stress hormone is an enemy army attacking them, making them weak and sick.
• The Experiment: They added the Daylily juice to the sick soldiers.
• The Result:
  • Survival: The Daylily juice saved the soldiers from dying. In fact, it worked just as well as, or sometimes even better than, the famous antidepressant drug Fluoxetine (Prozac).
  • The Cleanup Crew: The juice lowered the "trash" (inflammation/TNF-α) and the "stress hormones" (CORT).
  • The Fertilizer: It boosted the "fertilizer" (BDNF) and the "mood chemical" (Serotonin/5-HT).

---

🏆 The Takeaway

This study is a "trifecta" of modern science:

1. Green Tech: They found a clean, efficient way to harvest the medicine using ultrasound and safe solvents.
2. Digital Detective Work: They used AI and big data to map out exactly how the flower fights depression on a molecular level.
3. Real-World Proof: They showed in the lab that this flower extract can heal stressed brain cells, potentially offering a new, multi-target way to treat depression that is safer and more holistic than current drugs.

In short: The Daylily isn't just a pretty flower; it's a multi-tool for the brain. It doesn't just fix one broken part; it repairs the whole system by calming inflammation, feeding neurons, and balancing stress hormones. The researchers have now built the blueprint to turn this ancient remedy into a modern, green medicine.

Technical Summary

Title

Process optimization and antidepression multi-target mechanisms of Total Flavonoids from Hemerocallis citrina Baroni: An integrated approach combining DES-UAE, network pharmacology, and experimental validation.

1. Problem Statement

• Clinical Need: Depression is a global health burden with limited treatment efficacy (30–40% response rates), delayed onset of action, and significant side effects associated with current first-line pharmacotherapies. There is an urgent need for safer, multi-target interventions.
• Resource Underutilization: Hemerocallis citrina Baroni (Daylily) is a traditional Chinese medicine with known "calming" properties, but its optimal extraction method for total flavonoids (TFHC) remains unestablished, and its specific molecular mechanisms for treating depression are not systematically characterized.
• Extraction Limitations: Conventional extraction methods often rely on toxic organic solvents and lack efficiency. There is a need for "green" extraction technologies that preserve bioactivity while maximizing yield.

2. Methodology

The study employed a four-stage integrated strategy:

A. Green Extraction Optimization (DES-UAE + RSM)

• Solvent System: Developed a Deep Eutectic Solvent (DES) system using Choline Chloride (ChCl) and Ethylene Glycol (EG).
• Screening: Tested various DES compositions against a 70% ethanol control.
• Optimization: Used Response Surface Methodology (RSM) with a Box–Behnken Design (BBD) to optimize four key parameters:
  • Solid-to-liquid ratio
  • Ultrasonication time
  • Ultrasonic power
  • Extraction temperature
• Quantification: Total flavonoid content was measured via the NaNO₂–Al(NO₃)₃–NaOH colorimetric method.

B. Phytochemical Profiling

• Technique: Ultra-Performance Liquid Chromatography coupled with Electrospray Ionization Tandem Mass Spectrometry (UPLC-ESI-MS/MS).
• Goal: Identify specific flavonoid constituents in the optimized extract.

C. Network Pharmacology & Molecular Docking

• Target Prediction: Retrieved active compounds from TCMSP and LC-MS data; predicted targets via UniProt.
• Disease Targets: Retrieved depression-related targets from GeneCards and OMIM.
• Network Construction: Identified intersection targets and constructed a Protein-Protein Interaction (PPI) network using STRING and Cytoscape to identify hub targets.
• Enrichment Analysis: Performed Gene Ontology (GO) and KEGG pathway enrichment analyses to map biological functions.
• Validation: Conducted molecular docking simulations (AutoDock Vina) to verify binding affinities between core flavonoids and hub targets.

D. In Vitro Experimental Validation

• Model: PC-12 cells treated with Corticosterone (CORT, 400 μM) to induce a depression-like neurotoxicity model (mimicking HPA axis hyperactivation).
• Assays:
  • Cytotoxicity: MTT assay to determine safe dosing ranges and neuroprotective efficacy.
  • Biomarker Quantification: ELISA to measure levels of Serotonin (5-HT), Brain-Derived Neurotrophic Factor (BDNF), Tumor Necrosis Factor-alpha (TNF-α), and Corticosterone (CORT) in cell supernatants.
• Control: Compared against Fluoxetine (FLX), a standard antidepressant.

3. Key Contributions

1. Process Innovation: Established a novel, green, and efficient extraction protocol for TFHC using ChCl-EG DES, optimized via RSM, yielding significantly higher flavonoid recovery than conventional ethanol methods.
2. Mechanistic Elucidation: Deciphered the "multi-component, multi-target, multi-pathway" mechanism of TFHC, moving beyond reductionist single-target theories to a systems-level understanding of its antidepressant action.
3. Experimental Validation: Provided robust in vitro evidence confirming that TFHC not only protects neurons from stress-induced injury but also modulates specific neurochemical pathways (neuroinflammation, neurotrophic support, and HPA axis regulation).
4. Comparative Efficacy: Demonstrated that TFHC exhibits neuroprotective efficacy comparable to or superior to Fluoxetine in specific metrics, particularly in reducing CORT-induced cytotoxicity.

4. Key Results

Extraction Optimization

• Optimal DES: ChCl:Ethylene Glycol (1:4 molar ratio) with 60% water content.
• Optimal Conditions: Solid-to-liquid ratio 1:42 (g/mL), 57 min, 156 W, 64°C.
• Yield: Achieved 16.63 ± 0.13 mg/g of Total Flavonoids, with a relative error of only 0.78% compared to the RSM prediction.

Chemical Profiling

• Identified 14 flavonoid compounds, including Rutin, Quercetin, Kaempferol, Luteolin, and Apigenin.
• Rutin and Quercetin were the most abundant constituents.

Network Pharmacology

• Core Targets: Identified 6 hub targets: AKT1, TNF, IL6, IL1β, TP53, and PTGS2.
• Key Pathways: Enriched in PI3K-AKT signaling, TNF signaling, Neurotrophin signaling, and Lipid metabolism/Atherosclerosis pathways.
• Mechanism Hypothesis: TFHC acts by suppressing neuroinflammation, inhibiting apoptosis (via TP53), and enhancing synaptic plasticity/neurogenesis (via AKT1/BDNF).
• Docking: Confirmed strong binding affinities (ΔG ≤ -4.25 kcal/mol) between major flavonoids and the core targets.

In Vitro Validation

• Safety: TFHC showed no cytotoxicity at 0.1–1.0 mg/mL, whereas Fluoxetine showed significant toxicity at higher concentrations.
• Neuroprotection: TFHC (0.75 mg/mL) significantly reversed CORT-induced cell death, restoring viability to ~90% (superior to FLX's peak effect).
• Biomarker Modulation:
  • 5-HT & BDNF: TFHC significantly restored depleted levels of Serotonin and BDNF.
  • TNF-α & CORT: TFHC significantly suppressed the elevation of pro-inflammatory TNF-α and intracellular Corticosterone.
  • Comparison: TFHC demonstrated superior efficacy in normalizing HPA axis dysfunction (CORT levels) compared to Fluoxetine.

5. Significance

• Therapeutic Potential: This study positions Hemerocallis citrina Baroni flavonoids as a promising candidate for next-generation, multi-target antidepressants that address the complex, heterogeneous nature of depression (inflammation, neurotrophic deficits, and HPA axis dysregulation) simultaneously.
• Green Chemistry: The developed DES-UAE method offers a sustainable, scalable, and eco-friendly alternative to traditional solvent extraction for pharmaceutical production.
• Scientific Framework: The study validates a comprehensive workflow (Green Extraction → Chemical Profiling → Network Pharmacology → Experimental Validation) for elucidating the mechanisms of complex natural products, providing a blueprint for future TCM research.
• Clinical Implication: The findings suggest that TFHC could serve as a novel therapeutic agent or a dietary adjunct with a favorable safety profile and a mechanism of action distinct from conventional monoaminergic antidepressants.